| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Maria C Jockers-Scherübl, Uta Matthies, Heidi Danker-Hopfe, Undine E Lang, Richard Mahlberg, Rainer Hellwe. Chronic cannabis abuse raises nerve growth factor serum concentrations in drug-naive schizophrenic patients. Journal of psychopharmacology (Oxford, England). vol 17. issue 4. 2004-05-07. PMID:14870957. |
on average, heavy cannabis consumers suffered their first episode of schizophrenia 3.5 years (n = 21) earlier than schizophrenic patients who abstained from cannabis. |
2004-05-07 |
2023-08-12 |
Not clear |
| Maria C Jockers-Scherübl, Uta Matthies, Heidi Danker-Hopfe, Undine E Lang, Richard Mahlberg, Rainer Hellwe. Chronic cannabis abuse raises nerve growth factor serum concentrations in drug-naive schizophrenic patients. Journal of psychopharmacology (Oxford, England). vol 17. issue 4. 2004-05-07. PMID:14870957. |
these results indicate that cannabis is a possible risk factor for the development of schizophrenia. |
2004-05-07 |
2023-08-12 |
Not clear |
| Maria C Jockers-Scherübl, Uta Matthies, Heidi Danker-Hopfe, Undine E Lang, Richard Mahlberg, Rainer Hellwe. Chronic cannabis abuse raises nerve growth factor serum concentrations in drug-naive schizophrenic patients. Journal of psychopharmacology (Oxford, England). vol 17. issue 4. 2004-05-07. PMID:14870957. |
this might be reflected in the raised ngf-serum concentrations when both schizophrenia and long-term cannabis abuse prevail. |
2004-05-07 |
2023-08-12 |
Not clear |
| Alan I Green, Mauricio F Tohen, Robert M Hamer, Stephen M Strakowski, Jeffrey A Lieberman, Ira Glick, W Scott Clar. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol. Schizophrenia research. vol 66. issue 2-3. 2004-05-04. PMID:15061244. |
co-occurring substance use disorders, mostly involving alcohol, cannabis or cocaine, occur commonly in patients with schizophrenia and are associated with increased morbidity and mortality. |
2004-05-04 |
2023-08-12 |
Not clear |
| Natalie D Veen, Jean-Paul Selten, Ingeborg van der Tweel, Wilma G Feller, Hans W Hoek, René S Kah. Cannabis use and age at onset of schizophrenia. The American journal of psychiatry. vol 161. issue 3. 2004-04-19. PMID:14992976. |
cannabis use and age at onset of schizophrenia. |
2004-04-19 |
2023-08-12 |
Not clear |
| Natalie D Veen, Jean-Paul Selten, Ingeborg van der Tweel, Wilma G Feller, Hans W Hoek, René S Kah. Cannabis use and age at onset of schizophrenia. The American journal of psychiatry. vol 161. issue 3. 2004-04-19. PMID:14992976. |
the purpose of the study was to assess the independent influences of gender and cannabis use on milestones of early course in schizophrenia. |
2004-04-19 |
2023-08-12 |
Not clear |
| Louise Arseneault, Mary Cannon, John Witton, Robin M Murra. Causal association between cannabis and psychosis: examination of the evidence. The British journal of psychiatry : the journal of mental science. vol 184. 2004-03-25. PMID:14754822. |
controversy remains as to whether cannabis acts as a causal risk factor for schizophrenia or other functional psychotic illnesses. |
2004-03-25 |
2023-08-12 |
Not clear |
| Franjo Grotenhermen, Kirsten Müller-Vah. IACM 2nd Conference on Cannabinoids in Medicine. Expert opinion on pharmacotherapy. vol 4. issue 12. 2004-03-12. PMID:14640935. |
a workshop on psychiatry focused on effects of cannabis use on onset, incidence and the course of schizophrenia. |
2004-03-12 |
2023-08-12 |
Not clear |
| F Smit, L Bolier, P Cuijper. [Cannabis use as a probable causative factor in the later development of schizophrenia]. Nederlands tijdschrift voor geneeskunde. vol 147. issue 44. 2004-01-06. PMID:14626837. |
[cannabis use as a probable causative factor in the later development of schizophrenia]. |
2004-01-06 |
2023-08-12 |
Not clear |
| Karla Soares-Weiser, Mark Weiser, Michael Davidso. [Use of cannabis in adolescence and risk of schizophrenia]. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999). vol 25. issue 3. 2003-12-18. PMID:12975685. |
[use of cannabis in adolescence and risk of schizophrenia]. |
2003-12-18 |
2023-08-12 |
Not clear |
| Sami Pirkol. [Cannabis and schizophrenia]. Duodecim; laaketieteellinen aikakauskirja. vol 119. issue 13. 2003-09-22. PMID:12908181. |
[cannabis and schizophrenia]. |
2003-09-22 |
2023-08-12 |
Not clear |
| A Dervaux, X Laqueille, M-C Bourdel, M-H Leborgne, J-P Olié, H Lôo, M-O Kreb. [Cannabis and schizophrenia: demographic and clinical correlates]. L'Encephale. vol 29. issue 1. 2003-05-14. PMID:12640322. |
[cannabis and schizophrenia: demographic and clinical correlates]. |
2003-05-14 |
2023-08-12 |
Not clear |
| Jean Costenti. [Recent neurobiological data on cannabis]. Bulletin de l'Academie nationale de medecine. vol 186. issue 2. 2003-04-29. PMID:12145839. |
we here report an evaluation of experimental data which reveal in animals a psychological dependence, common to all addictive drugs; a physical dependence, which is considered up to now as the characteristic of "hard addictive drugs"; the incentive effect that cannabis should exert on the inclination to abuse other addictive drugs, especially heroin; and finally the close relationships which seem to exist between cannabis and schizophrenia. |
2003-04-29 |
2023-08-12 |
Not clear |
| Alan I Green, Ellen S Burgess, Ree Dawson, Suzannah V Zimmet, Rael D Strou. Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone. Schizophrenia research. vol 60. issue 1. 2003-04-24. PMID:12505141. |
alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone. |
2003-04-24 |
2023-08-12 |
Not clear |
| Alan I Green, Ellen S Burgess, Ree Dawson, Suzannah V Zimmet, Rael D Strou. Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone. Schizophrenia research. vol 60. issue 1. 2003-04-24. PMID:12505141. |
alcohol and cannabis use disorders worsen the course of schizophrenia. |
2003-04-24 |
2023-08-12 |
Not clear |
| Alan I Green, Ellen S Burgess, Ree Dawson, Suzannah V Zimmet, Rael D Strou. Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone. Schizophrenia research. vol 60. issue 1. 2003-04-24. PMID:12505141. |
we describe a retrospective study of the effects of the novel antipsychotics risperidone (risp) and clozapine on alcohol and cannabis use in patients with schizophrenia or schizoaffective disorder and comorbid alcohol and/or cannabis use disorder. |
2003-04-24 |
2023-08-12 |
Not clear |
| G Bersani, V Orlandi, S Gherardelli, P Pancher. Cannabis and neurological soft signs in schizophrenia: absence of relationship and influence on psychopathology. Psychopathology. vol 35. issue 5. 2003-04-22. PMID:12457020. |
cannabis and neurological soft signs in schizophrenia: absence of relationship and influence on psychopathology. |
2003-04-22 |
2023-08-12 |
Not clear |
| G Bersani, V Orlandi, S Gherardelli, P Pancher. Cannabis and neurological soft signs in schizophrenia: absence of relationship and influence on psychopathology. Psychopathology. vol 35. issue 5. 2003-04-22. PMID:12457020. |
cannabis is a possible risk factor for the onset of schizophrenia and can induce neurocognitive, behavioural and motor co-ordination alterations. |
2003-04-22 |
2023-08-12 |
Not clear |
| Elie G Karam, Philippe F Yabroudi, Nadine M Melhe. Comorbidity of substance abuse and other psychiatric disorders in acute general psychiatric admissions: a study from Lebanon. Comprehensive psychiatry. vol 43. issue 6. 2003-03-21. PMID:12439834. |
of these, 64.9% were found to have comorbid psychiatric disorders with specific relations between individual substances and psychiatric diagnoses identified such as cocaine and bipolar disorder (42.1%), and cannabis and schizophrenia (44.8%). |
2003-03-21 |
2023-08-12 |
Not clear |
| M Fritzsch. Impaired information processing triggers altered states of consciousness. Medical hypotheses. vol 58. issue 4. 2003-01-30. PMID:12027532. |
in the search for candidate genes and the protection of vulnerable individuals from cannabis abuse, non-linear eeg analysis of kolmogorov information could thus present us with a novel diagnostic tool to directly assess the breakdown of information processing in schizophrenia. |
2003-01-30 |
2023-08-12 |
Not clear |